Blood group antibody:PrThr:Pt:Ser/Plas:Ord:Blood group antibody screen.PEG

Preferred Label : Blood group antibody:PrThr:Pt:Ser/Plas:Ord:Blood group antibody screen.PEG;

LOINC status : ACTIVE;

LOINC display name : Blood group antibody screen PEG method Ql;

LOINC long common name : Blood group antibody screen [Presence] in Serum or Plasma by Polyethylene glycol (PEG) method;

LOINC short name : Bld gp Ab Scn SerPl Ql PEG;

LOINC description : Antibody screening is used to demonstrate unexpected antibodies (other than ABO) and is performed on both donors and recipients to help ensure compatibility between recipient antibodies and donor red cells. Polyethylene glycol (PEG) is a blood bank agent that reduces antibody screening incubation time by excluding water and therefore allowing red cells to come closer together during centrifugation. PEG may enhance the expression of warm antibodies and auto-antibodies. A downside to PEG is that use may lead to false positive reactions at 37C from nonspecific agglutination. An advantage of PEG use is that it may provide greater sensitivity than LISS or albumin.;

Details

Origin ID

75265-9;

UMLS CUI

C3846750;

Has component
- Blood [LOINC component]
- Blood group [LOINC component]
- Blood group antibody screen [LOINC component]
Has method
- Blood group antibody screen [LOINC method]
- Polyethylene glycol (PEG) method [LOINC method]
- Polyethylene glycol (PEG) method [LOINC method]
- Toxicology screen [LOINC method]
Has property
- Presence or Threshold [LOINC Property]
Has scale
- Ord [LOINC scale]
Has system
- Plasma [LOINC System]
- Serum [LOINC System]
- Serum or Plasma [LOINC System]
Has time aspect
- Point in time (spot) [LOINC time aspect]
Semantic type(s)
- Clinical Attribute [UMLS semantic type]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients